Position in IBRX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,817,665
+$3,526,375 QoQ
Shares Held
550,276
+226.9% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 403 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Derivatives in IBRX
reported options exposure · as of Jun 30, 2026CallValue
$437,750
CallShares
50,000
PutValue
$437,750
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. IBRX ranks #66 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in IBRX
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,817,665 | 550,276 | Shares | Defined | 2026-08-03 | |
| 2026-06-30 | $437,750 | 50,000 | Put | Defined | 2026-08-03 | |
| 2026-06-30 | $437,750 | 50,000 | Call | Defined | 2026-08-03 | |
| 2026-03-31 | $383,500 | 50,000 | Put | Defined | 2026-05-11 | |
| 2026-03-31 | $383,500 | 50,000 | Call | Defined | 2026-05-11 | |
| 2026-03-31 | $1,291,290 | 168,356 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $218,811 | 110,511 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,859,716 | 2,381,999 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $6,565,356 | 2,486,878 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $8,171,132 | 2,714,662 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $984,513 | 384,576 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $408,716 | 109,870 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $688,790 | 108,986 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $6,059,754 | 1,128,446 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,566,350 | 312,022 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $10,193 | 6,032 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $120,968 | 43,514 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $14,070 | 7,731 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,077,907 | 212,605 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $1,857,010 | 373,644 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $54,787 | 14,728 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $522,694 | 93,172 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $2,331,649 | 383,495 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $1,796,796 | 184,476 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $4,285,613 | 300,113 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $4,041,687 | 170,248 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 NK | — | 29,031 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 NK | — | 3,178 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 NK | — | 3,928 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 NK | — | 2,939 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||